Delivery Order SPE2DB20D1110-SPE2DB25FK42K
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,224.45 to AmerisourceBergen Drug Corp for 180 tablets of Janumet XR 50-1,000 mg on September 16, 2025, with a completion date of September 17, 2025. This competitively awarded, firm fixed-price contract involves pharmaceutical delivery to support federal medical procurement needs. The contract was fulfilled by AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,659.77 for Janumet XR 50-1,000 mg tablets (180-count units) on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $2,511.68. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. As a child contract under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Janumet XR 50-1,000 mg tablets in quantities of 180 units. This contract represents a firm fixed-price delivery order valued at $21,902.08, with an ultimate completion date of September 2, 2025. The award was made competitively without set-aside restrictions and is being performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,179.32 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (60 count) on August 26, 2025, with a completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order was placed without a set-aside designation and represents a routine pharmaceutical procurement to support federal medical supply needs. The product will be delivered to AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of JANUMET XR 50-1,000 mg tablets (180-count units). This firm fixed-price delivery order, valued at $29,236.05, represents a competitive award with no set-aside designation and a completion date of June 20, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $3,078.36. This firm fixed-price delivery order, which is not set aside for any specific business category, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is identified as...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This delivery order, valued at approximately $39,906, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This non-set-aside contract, valued at approximately $35,000, represents a firm fixed-price delivery order with an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $3,514.89. This is a firm fixed-price delivery order with no set-aside designation, executed under a competitive procurement process. The delivery order is scheduled for completion by September 29, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken,...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK42KDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,343.04 on September 17, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by September 18, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medications and medical commodities to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains, from specialty medications to generic drugs and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/17/25 |